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Abstract Pluripotent stem cells (PSCs) are a unique type
of cells because they exhibit the characteristics of self-
renewal and pluripotency. PSCs may be induced to dif-
ferentiate into any cell type, even male and female germ
cells, suggesting their potential as novel cell-based thera-
peutic treatment for infertility problems. Spermatogenesis
is an intricate biological process that starts from self-re-
newal of spermatogonial stem cells (SSCs) and leads to
differentiated haploid spermatozoa. Errors at any stage in
spermatogenesis may result in male infertility. During the
past decade, much progress has been made in the deriva-
tion of male germ cells from various types of progenitor
stem cells. Currently, there are two main approaches for the
derivation of functional germ cells from PSCs, either the
induction of in vitro differentiation to produce haploid cell
products, or combination of in vitro differentiation and
in vivo transplantation. The production of mature and
fertile spermatozoa from stem cells might provide an
unlimited source of autologous gametes for treatment of
male infertility. Here, we discuss the current state of the art
regarding the differentiation potential of SSCs, embryonic
stem cells, and induced pluripotent stem cells to produce
functional male germ cells. We also discuss the possible
use of livestock-derived PSCs as a novel option for animal
reproduction and infertility treatment.
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bFGF Basic fibroblast growth factor
BMP Bone morphogenic protein
DNMT3 DNA methyltransferase 3
DNMT3L DNA methyltransferase 3-like
E Embryonic
EBs Embryoid bodies
ESCs Embryonic stem cells
EpiSCs Epiblast stem cells
FACS Fluorescence-activated cell sorting
GM Genetically modified
GDNF Glial cell line-derived neurotrophic factor
hESCs Human embryonic stem cells
hiESCs Human induced embryonic stem cells
hiPSCs Human induced pluripotent stem cells
ICM Inner cell mass
ICSI Intracytoplasmic sperm injection
iPSCs Induced pluripotent stem cells
LIF Leukemia inhibitory factor
mESCs Mouse embryonic stem cells
MEHP Mono-(2-ethylhexyl) phthalate
miRNA Micro-RNA
Mvh Mouse vase homologue
PGCs Primordial germ cells
PSCs Pluripotent stem cells
SSCs Spermatogonial stem cells
SSEA-1 Stage specific antigen-1
SSEA-4 Stage specific antigen-4
TET1 Ten–eleven translocation methylcytosine
dioxygenase
TP2 Transition protein 2
Introduction
Approximately 50–60 % of human infertility is caused by
defects in the male germ line [1]. Current infertility treat-
ments include intrauterine insemination, ovulation
induction for in vitro fertilization, and intracytoplasmic
sperm injection (ICSI), which usually is associated with
low efficiency and unwanted side effects in the offspring
most likely caused by epigenetic aberrations [2]. However,
these treatments are available only to patients who are able
to produce functional gametes.
Stem cells are pluripotent cells that have the capacity for
indefinite self-renewal and can generate multiple cell types
with specific functions in the body [3]. Spermatogenesis is
an intricate process that starts with self-renewal of sper-
matogonial stem cells (SSCs) and leads to fully
differentiated functional haploid spermatozoa (Fig. 1).
Perturbations at any stage of spermatogenesis may result in
infertility; because the process is error prone, and defective
sperm production is thought to be responsible for 15–50 %
of all infertility cases [2].
Oct4 expression is critically involved in the regulation
of pluripotency and is found in the inner cell mass (ICM) of
blastocysts, the epiblast, and the primordial germ cells
(PGCs), but is repressed in somatic cells [4]. PGCs migrate
through the hindgut to the genital ridge, where the ovaries
and testis are formed. After termination of migration, PGCs
start to express a marker gene for post-migratory germ
cells, Ddx4 (mouse vasa homologue: Mvh) [5], which
initiates sex-specific development. Following migration,
male PGCs enter mitotic arrest, and after birth, male germ
cells are reactivated to start spermatogenesis. By day
E15.5, oogonia are formed in females and gonocytes are
formed in males. Gonocytes persist until shortly after birth,
and SSCs are formed between postpartum days 0 and 6 in
male mice. The transition of gonocytes to SSCs lasts sev-
eral months in livestock and years in humans and other
primates [6].
Male germ cells grown from gonocytes continue to self-
renew as SSCs throughout life. SSCs from neonatal and
adult mice can develop into pluripotent stem cells (PSCs)
when cultured under specific conditions in vitro [7, 8]. The
establishment of human adult germ line stem cells from
human testicular tissue has been reported [9, 10].
Here, we review the current status of the differentiation
potential of SSCs, embryonic stem cells (ESCs), and
induced pluripotent stem cells (iPSCs) towards male germ
cells. We discuss their potential for use in reproductive
medicine and for gaining a better understanding of stem
cell development and spermatogenesis. In addition, we
discuss the potential use of large domestic animal-derived
PSCs for drug screening, infertility treatment, production
of genetically modified (GM) livestock, and human disease
models.
Male germ cell generation in vitro
In the past decade, significant progress has been made in
the derivation of male germ cells from various types of
stem cells. Currently, two approaches are used for gener-
ating male germ cells from PSCs: (1) in vitro
differentiation to haploid cells, and (2) a combined
approach by using in vitro differentiation and in vivo
transplantation.
Two main sources of PSCs exist in early mammalian
embryos: the ICM of preimplantation blastocysts and the
epiblast of pre- and post-implantation embryos, which are
termed ESCs and epiblast stem cells (EpiSCs), respectively
[11–13]. Mouse embryonic stem cells (mESCs) can be
differentiated into all types of cells, including PGCs and













undergo further differentiation and meiosis to immature
gametes, which in turn form blastocysts after fertilization
[14, 15]. Several groups have reported the delivery of live
pups from in vivo differentiated sperm cells [16, 17]. A
similar developmental capacity was proposed for human
and primate ESCs [18–22]. HESCs and hiPSCs are capable
of differentiating into the three germ layers and into germ
cells. Human iPSCs have been used as a model system to
understand the genetic and epigenetic basis of germ cell
specifications [23], and germ cell-like cells could be
derived by in vitro induction.
It is known that hESCs are more similar to mouse
EpiSCs than mESCs [13]. Two different pluripotency
states are represented by these cell types: (1) a naı¨ve state,
which is characteristic of mESCs, and (2) a primed
pluripotent state, which is typical for EpiSCs and hESCs.
These cells do not have the capacity to form germ cell line-
competent chimeras upon injection into blastocysts [24]. In
the laboratory mouse, a properly primed pluripotency state
is associated with the induction of an epiblast-like state
prior to germ cell derivation, whereas in humans, the cor-
rect entry into meiosis led by RNA-binding proteins seems
to be the major obstacle (Fig. 2).
IPSCs have been generated by over-expression of vari-
ous combinations of transcription factors (e.g., OCT4,






































of mammalian PSCs into germ
cells in vitro. The totipotent
zygote is the earliest cell. The
ICM in blastocysts contains all
cell types forming the entire
organism, and ESCs have been
established from ICM cells
under suitable in vitro culture
conditions. Following germ line
specification, PGCs appear first
in the extraembryonic
mesoderm. The germ line
potential is preserved during
embryo development in OCT4?
cells located in ICM cells of the
blastocyst, epiblast stem cells,
PGCs, and gonocytes in male
gonads. Both ESCs and iPSCs
can be differentiated to PGC-
like cells under in vitro culture
conditions with BMP4 and/or
GDNF. The development of
germ cells, already during the
postnatal period, is sex-specific.
Male germ cells enter mitotic
arrest and are reactivated to
initiate spermatogenesis after
birth. Female germ cells enter
meiosis and undergo meiotic
arrest until after birth [80, 83].
eBlastocyst equine blastocyst,
mESCs mouse embryonic stem
cells, mEpiblast mouse epiblast,
hiPSCs human induced
pluripotent stem cells












26]. Recent reports have shown that hiPSCs can enter
meiosis and, in some cases, produce haploid products [27–
30]. By contrast, the differentiation potential of ESCs and
iPSCs to germ cells has not been reported in livestock
animals.
Recently, endocrine disruptors have been suggested to
have profound trans-generational effects on male germ
cell function and have been associated with infertility
and tumor formation [31–35]. Exploitation of in vitro
culture systems to support mammalian germ cells might
improve the development of novel methods for moni-
toring putative detrimental effects of reproductive
toxicants. We have demonstrated that bovine testicular
iPSCs are useful for screening the toxicity of environ-
mental disruptors, such as phthalate esters by examining
their effects on the maintenance of stemness and
pluripotency, and for identifying signaling pathways that
might be affected by disruptors [36, 37]. Modeling
spermatogenesis in vitro has been employed to examine
the effects of environmental toxicants on the differenti-
ation process to spermatozoa [38]. This represents a
unique platform for assessing the toxicity of various
environmental disruptors on human reproductive func-
tions in a rather straightforward manner.
Restoring fertility following SSC transplantation
into the testis
The most direct assay to confirm the biological capacity of
SSCs is functional transplantation. Re-transplantation of
SSCs obtained from testicular biopsies restored fertility in
infertile recipient mice [39–45]. For SSC transplantation, a
donor testis-derived cell suspension is injected into the sem-
iniferous tubules of a recipient male, inwhich the endogenous
germ cells have been depleted by treatment with chemotoxic
drugs (e.g., busulfan), or it is injected into an animal that is
naturally devoid of germ cells (e.g., W/Wv mutant males).
Successful transplantation of SSCs with the production of
viable spermatozoa has also been reported in livestock ani-
mals, including pigs, cattle, sheep, and goats [46–49].
Functional sperm derived from sheep and goat SSCs in the
host testis produced donor-derived progeny [48, 54]. SSC
transplantation is the only method for identifying fully func-
tional SSCs and confirming their biological activity.
The testicles are an immune-privileged site that is cru-
cial for successful allogenic SSC transplantation between
unrelated, immunocompetent individuals [46, 48, 50]. In
nonhuman primates, treatment with a humanized mono-
clonal antibody against CD154 prevented acute renal
Fig. 2 Schematic model of germ cell derivation in vitro. a Mouse
embryonic stem cells (mESCs) or mouse induced pluripotent stem
cells (miPSCs), in general PSCs, can be induced into an epiblastic-
like (mEpi-like) cells which are able to respond to the signaling
pathway started by BMP4 [17, 120, 121]. A primordial germ cell
(PGC)-like cells are induced and these cells, in an appropriate in vivo
microenvironment (i.e., transplantation into neonatal mouse testis or
ovarian bursa) become functional spermatocytes or oocytes. After
intracytoplasmic sperm injection (ICSI) these gametes generate fertile
and healthy offspring of both sexes. b Human pluripotent stem cells
(hPSCs) either human embryonic stem cells (hESCs) or human
induced pluripotent stem cells (hiPSCs) present a primed pluripotency
state, more similar to a mEpi-like cells, and they can directly respond
to BMP4 signaling to attain a PGC-like status [122–126]. PGC-like
cells need the presence of different RNA-binding proteins, to progress
meiosis and form haploid cells in vitro after induction by retinoic acid
(RA) and to express the correct spermatogonial markers when
subjected to in vivo microenvironment control after xenotransplan-
tation in immunosuppressed mouse testes. SSC spermatogonial stem
cell, Spg spermatogonia













allograft rejection [51]. SSC transplantation leads to
restoration of fertility in males after successful tumor
treatment, suggesting SSC transplantation as an emerging
clinical application [43, 52–56]. Recently, SSCs were
successfully transplanted into the testes of recipient
macaques that had been treated with busulfan to destroy the
endogenous sperm cell population [57]. The donor geno-
types were found in ejaculated sperm of the recipients and
mature ejaculated sperm led to blastocyst development
after ICSI in Rhesus oocytes, clearly indicating functional
spermatogenesis in the foster testes that had been rendered
sterile by prior chemotherapy. Thus, in cases of a deficient
testicular environment or in the absence of differentiated
haploid germ cells or spermatozoa, SSC transplantation
may be a valuable therapeutic option to restore fertility.
The findings in large animals and nonhuman primates are
promising for the application of transplantation of human
SSCs; for example, tissue biopsies obtained from adoles-
cent male patients prior to chemotherapy may be stored to
produce functional germ cells for later use after successful
cancer treatment [57, 58].
Enhancement of SSC self-renewal and stemness
in vitro
The core ESC regulatory transcription factors that regulate
self-renewal and pluripotency include OCT4, SOX2, and
NANOG [59–64]. Expression of Oct4, Sox2, Klf4, and
c-Myc, rather than Nanog, was observed in mouse SSC
in vitro, but tumor formation after transplantation was not
observed [65]. NANOG expression was shown to be
essential for PGC maturation in the genital ridge during
fetal development [66]. In our studies, bovine testicular
cells did not express endogenous OCT4, NANOG, or
SOX2; instead, they expressed KLF4 and c-MYC [67]. By
contrast, bovine iPSCs expressing pluripotency markers,
including OCT4, NANOG, SOX2, STAT3, c-MYC, KLF4,
TERT, and DNA methyltransferase 3 (DNMT3) have been
reported; benign cystic teratomas containing derivatives of
the three germ layers were observed after subcutaneous
transplantation into nude mice [36, 37]. These data suggest
that NANOG plays a critical role in the ability to contribute
to teratoma formation as an ultimate proof of pluripotency.
Speculatively, silencing of NANOG expression may be
essential for maturation of SSCs from PGCs or gonocytes.
Sato et al. [65] demonstrated the derivation of functional
sperms from mouse SSCs using an in vitro organ culture
system. The cells were cultured in explanted neonatal testis
tissues, and sperm cells could be differentiated from SSCs;
ultimately viable sperm gave rise to offspring after micro
insemination. These results seem to be applicable to other
species, including humans and large domestic species. The
technology requires explant culture with testicular tissue to
serve as host incubator [66], which, however, may pose
additional challenges related to hygiene and variability. In
contrast, human SSCs that were cultured in medium sup-
plemented with retinoic acid and stem cell factor can
differentiate into haploid spermatids that were microin-
jected into mouse oocytes and showed evidence of
fertilization potential [67].
Progress in stem cell technologies might lead to new
cell-based infertility treatments if immunologically com-
patible patient-specific cells can be derived. Using SSCs
for autologous cell-based therapy would be superior to
ESC-based treatments, because it avoids the ethical prob-
lems associated with the use of human ESCs. Moreover,
studies on SSCs may offer unique insight into one of the
earliest fate decisions of ESCs or EpiSCs and into the
biology of SSCs, which are of fundamental importance for
the continuity of species [6].
PSCs to screen for environmental
toxicant-associated male infertility
Numerous studies have confirmed that environmental
endocrine disruptors have adverse effects on male fertility;
phthalate derivatives lead to testicular atrophy, decreased
testicular weight and lower testosterone level [68–71]. The
detachment of germ cells from the seminiferous epithelium
and the increased incidence of germ cell apoptosis have
been observed in young peripubertal rodents after exposure
to mono-(2-ethylhexyl) phthalate (MEHP) [71]. The num-
ber of germ cells was significantly reduced in cultured
human fetal testes after exposure to 10-4 M MEHP for
3 days, mainly associated with a dramatic increase in
apoptosis [72]. The toxicity of environmental disruptors
such as cadmium [73], MEHP [74], and uranium [75], was
investigated using organ culture systems with human fetal
testes. Thus, the use of hESCs and iPSCs is promising for
monitoring potentially detrimental effects of environmental
disruptors.
Bovine iPSCs and testicular cells have been successfully
used as in vitro models to study the toxicity of phthalate
esters. We found that bovine iPSCs were more resistant to
androgen receptor (AR)-dependent apoptosis than testicu-
lar cells, most likely attributed to regulation of the AR-
p21Cip1 cascade via p53, which showed significantly
enhanced expression. Phthalate esters significantly reduced
AR expression in bovine iPSCs. Collectively, these studies
indicate that iPSCs may be useful for screening for adverse
effects from endocrine disruptor [36, 37]. This screening
system has also promised as a useful model for studying
the effects of environmental factors on human germ cell
development.












Derivation of gametes from mammalian adult
tissues, and germ line cell differentiation
from ESCs and iPSCs
Functional adult germ line stem cells can be derived from
human testes and adult mouse and human ovaries [9, 10,
76–78]. However, stem cells from human testicular tissue
did not form teratomas after transplantation into immune-
deficient mice, suggesting limited pluripotency [9, 10].
Mitotically active oogonial stem cells could be isolated
from the surface of mouse adult ovaries and human ovarian
tissues by sorting for DDX-expressing cells [78]. However,
other investigators did not find mitotically active female
germ line progenitors in mouse ovaries. Moreover, Ddx4-
expressing cells from postnatal mouse ovaries did not enter
meiosis and did not develop to oocytes during de novo
folliculogenesis under their experimental conditions [79].
Gamete derivation in vitro from PSCs is challenging
because many PGC markers are identical to PSC markers
[80], which makes it extremely difficult to discriminate
early embryonic germ line cells from PGCs.
Hu¨bner et al. [81] were the first to report the in vitro
gamete production from mouse ESCs carrying the Oct4
reporter gene. Ovarian follicle-like structures were
observed under culture conditions without feeder layer or
growth factors. Toyooka et al. [14] described for the first
time the derivation of male germ cells from mouse ESCs
carrying a Ddx4 (Mvh) reporter construct. These authors
used embryoid bodies (EBs) as the starting material and
induced EBs to differentiate in suspension culture in the
absence of leukemia inhibitory factor (LIF). Ddx4? cells
gradually appeared in the EBs, suggesting the presence of
cells with the characteristics of post-migratory PGCs in
EBs. Subsequently, purified Ddx4? cells were transplanted
together with male genital ridge cells into adult mouse
testes. The cell aggregates formed seminiferous tubules
that supported complete spermatogenesis derived from
purified Ddx4? cells. This study clearly demonstrates that
germ line specification and the emergence of post-migra-
tory PGCs occur spontaneously or are induced in EBs.
However, spermatozoa derived from PGCs could not
activate oocytes. Male PGCs could be derived from mouse
ESCs in vitro with the aid of EBs [15]. The cells sponta-
neously became post-meiotic and were capable of
activating oocytes after injection of PGC-derived male
haploid cells into EBs, using an antibody that specifically
reacted with specific stages of postnatal male germ cells up
to spermatozoa [15].
Nayernia et al. [16] reported the induction of male
gametes from ESCs and the successful production of off-
spring derived thereof. However, the low viability and
growth abnormalities in the progeny derived from in vitro-
derived germ cells indicated imprinting errors, suggesting
erroneous epigenetic reprogramming associated with the
development of male-specific germ cells under in vitro
conditions. Moreover, the remaining undifferentiated stem
cells in culture might cause teratomas after transplantation.
Further investigations into the epigenetic reprogramming
status in induced germ cells might provide valuable
information regarding sex-specific germ cell differentiation
in vitro. In vitro germ cell induction mechanisms have not
yet been sufficiently defined to allow for examining the
normal development of germ cells ex vivo. Further in vivo
studies are needed to establish the effectiveness of in vitro
systems as a reliable assay of germ cell development [80].
The expression profiles of marker genes in germ cells
and PSCs may provide important information for deriving
germ cells from those cells. Marker molecules for specific
types of stem cells are shown in Table 1. Basic fibroblast
growth factor (bFGF) and feeder cells increased the
expression of PGC marker genes such as VASA (DDX4),
DAZL, and OCT4 in human germ-like cells differentiated
from hESCs [85]. Tilgner et al. [20] reported the enrichment
of putative PGCs from hESCs that had been sorted using an
antibody specific for stage specific embryonic antigen-1
(SSEA-1). Gelatin-bound monolayers are obviously a
robust system for generating large number of differentiated
cells. However, these cells do not enter meiosis.
Transplantation of ESC-derived somatic cells or tissues
is promising for curing many human diseases. However,
derivation of gametes from unrelated ESCs is associated
with incompatibilities of the immune systems. Well-char-
acterized iPSCs may be a good option for obtaining
sufficient numbers of autologous cells. HiPSCs could be
successfully differentiated to post-meiotic cells without
over-expression of germ line-related transcription factors
[26]. Cells were cultured without bFGF as monolayers for
3 weeks and the pluripotency markers SSEA-4 and OCT4
were down-regulated at the end of this period. Under these
conditions, male germ-like haploid cells were obtained
from hiPSCs. Tilgner et al. [20] demonstrated for the first
time the meiotic competence of hiPSC-derived cells, which
suggests the possibility of producing human gametes
in vitro. The ability of hiPSCs and hESCs to differentiate
into presumptive SSC-like cells in vitro, and to contribute
to advanced spermatogenesis, including round spermatids,
was reported recently [30]. However, round spermatids
could not fertilize human oocytes. The feasibility and
safety of the culture systems will need to be established in
animal models.
Mouse ESCs and iPSCs can be induced to form epiblast-
like cells that, in turn, develop into PGC-like cells when the
culture medium is supplemented with BMP4 [17]
(Table 2). The resulting PGC-like cells were then













Table 1 Gene and surface marker expression profiles of pluripotent stem cells and germ cells
ESCs iPSCs PGCs SSCs Testis
m    h m     h     b m    h m    h m     h     b
OCT4 +     + +       +      + +     + +     + - - +/-
NANOG +     + + +      + +     + +     + - - +/-
STAT3 +     + +       +      + - + ND ND   ND +
AP +     + +       +      + +     + + ND ND   ND +/-
Teratoma formation +     + +       +      + ND  ND + ND ND   ND ND
SSEA-1 + - + - + +     + + + ND   ND +/-
SSEA-3/4 - + - +       + - + - + ND   ND +/-
VASA - - - - ND +     + +     + +     +    ND
BLIMP1 - ND +     ND    ND +    ND ND ND - ND   ND
DAZL - - - - ND +     + ND ND +    ND   ND
STRA8 - - +/- ND ND +    ND ND ND +    ND   ND
Reference [28, 57, 82] [25, 26, 36] [16, 17, 85] [30, 57, 64] [9, 26, 37]
Ţ
ţ
ND not determined or no information, m mouse, h human, b bovine, ESCs embryonic stem cells, iPSCs induced pluripotent stem cells, PGCs
primordial germ cells, SSCs spermatogonial stem cells, AP alkaline phosphatase
a Pluripotency markers
b Germ cell markers
Table 2 In vitro germ cell-like derivation from pluripotent stem cells
Animals Type of pluripotent stem cells Methods Germ cell-like formation References
Human ES cells Human BMP4, BMP8a, DAZ2, DAZL,
BOULE, RA
Germ cell-like cells [30]
Human ES cells and iPS cells Human BMP4, BMP8a, VASA, RA Germ cell-like cells [126]
Human iPS cells Human BMP4, BMP8a, DAZ2, DAZL,
BOULE, RA
Germ cell-like cells [31]
Human iPS cells Human BMP4, BMP8a, VASA, and




in the Y chromosome)
iPS cells Human BMP4, BMP8a, transplantation into
murine seminiferous tubules
Induced PGCs [128]
Human Umbilical cord Wharton’s jelly-
derived mesenchymal stem
cells (HuMSCs)
Human MSCs ? bFGF, EGF ? 5–7 days
co-cultured with sertoli cells (1–3 weeks)
Male germ-like cell [124]






Differentiation to EpiLCs with
bFGF ? ActivinA ? BMP4 ? PGCLC





Differentiation to EpiLCs with
bFCF ? Activin A ? BMP4 ? PGCLC
generation ? transplantation into




Differentiation to EpiLSCs with
bFGF ? Activin A ? Prdm1, Prdm14,
TFAP2C ? PGCLC generation
Sperm-like cells [123]













transferred to the testes of infertile mice and produced
sperm that were used for ICSI; transfer of the resulting
embryos into recipient females gave rise to viable off-
spring. This is the most advanced protocol for the deviation
of functional gametes from PSCs until now. Further
experiments are required before this system could be used
for therapeutic treatments in human patients because some
of the offspring showed malignant tumors in the neck area
[17]. Human iPSC-derived cells should be monitored
carefully to eliminate mutations, specifically in tumor
suppressor genes [83, 84].
Epigenetic control of germ cell development
A bimodal pattern of DNA methylation has been detected
during the specification and maturation of mouse male germ
cells (Fig. 3). PGCs derived from the epiblast at E6.5–E7.5
are stimulated by BMP4, then migrate from the epiblast to
the hindgut at E7.5–E9, and finally to the genital ridge at
E9.5–E11.5. In E6.5 mouse embryos, PGCs show DNA
hypermethylation with repression of certain genes [85]. The
epigenetic marks are erased during migration of PGCs [86],
particularly in imprinted genes and transposons of PGCs.
The re-establishment of DNA methylation in germ cells
initiates from the formation of pro-spermatogonia or
gonocytes. Although DNA methylation is acquired during
the prenatal mitotic arrest of the gonocytes, de novo and
maintenance of methylation occur only during mitosis of
spermatogonia andmeiotic prophase I,whereasmaintenance
methylation appears only during mitosis [87] (Table 3). The
global erasure of DNA methylation also occurs during early
embryonic development [88, 89].
DNMT3-like (DNMT3L) is involved in the maintenance
of DNA methylation in stem cells during the quiescent state
or during self-renewal of SSCs, whereas DNMT3a and
DNMT3b are not involved in this process. In addition to its
role in self-renewal, DNA methylation of SSCs may be
required for the transition from SSCs to differentiated sper-
matogonia. DNMT3a andDNMT3b transcripts remain at the
highest level in type A spermatogonia compared with other
types of male germ cells [90]. Studies into the roles of DNA
methyltransferases in SSC differentiation in mice are useful
for gaining a better understanding of the underlying bio-
logical principles and for the development of new therapies.
Expression of DNMT1, DNMT3a, and DNMT3b is
upregulated in leptotene and zygotene spermatocytes during
meiosis and spermatogenesis [91]. DNMT1 is present in
non-proliferative round spermatids, whereas DNMT3a and
DNMT3b maintain the methylation patterns through the de
novomethylation pathways, although the roles ofDNMT1 in
round spermatids remain to be solved. The role of ten–eleven
Fig. 3 Schematic diagram reveals the expression of DNA methyla-
tion profiles in mammalian spermatogenesis. Bimodal DNA
methylation patterns in male germ cell development. PGCs are
derived from the epiblast at E6.5 and migrate to the genital ridge.
During migration, the epigenetic marks are widely erased. After
erasure of the DNA methylation marks, reestablishment of the male
germ cell DNA patterns initiates from prospermatogonia to entering
meiosis. After fertilization, DNA patterns are broadly erased by active
demethylation, whereas the imprinted genes are maintained by
DNMT1 activity













translocation methylcytosine dioxygenase (TET1) has not
been elucidated in spermatogenesis, albeit it plays a signif-
icant role as a meiotic initiator in oocytes [92]. It remains to
be determined whether the biological function of TET1 in
spermatogenesis is similar to that in oocytes [92]. In contrast
to mouse, human DNMT1, DNMT3a, and DNMT3b are
expressed in pachytene spermatocytes [94]. However, in
both mice and humans, DNMT1, DNMT3a and DNMT3b
are highly expressed in round spermatids [93, 94]. DNMT1 is
present in non-proliferative round spermatids, whereas
DNMT3a and DMMT3b are expressed after the establish-
ment of the paternal methylation pattern. Thus, DNMT3a2
and DNMT3b may play a role in the de novo methylation
pathways, although the role of DNMT1 in round spermatids
remains to be solved.
In addition to DNAmethylation and demethylation, global
changes in histonemodifications, such as a decrease in histone
H3K9 dimethylation and an increase in histone H3K27
trimethylation, occur in the PGC genome [95, 96]. Although
the significance of the global changes in histonemodifications
remains unclear, it is likely that the alteration is required for
the acquisition of potency in the terminal products. A better
knowledge on the epigenetic profile during germ cell devel-
opment is crucial for understanding the underlying biological
mechanisms, and thus for developing suitable culture tech-
niques for germ cells, which, in turn, are major prerequisites
for developing new therapies with germ cells.
Micro-RNAs (miRNAs) in meiotic
and post-meiotic cells
A conditional knockout of Dicer 1 in mice disrupts meiotic
and post-meiotic development by decreasing the number of
mouse SSCs and by blocking differentiation [97, 98]. In
addition, loss of Dicer1 resulted in male infertility in mice
Table 3 miRNA that plays a regulatory role in spermatocyte meiosis and spermatogenesis
MiRNA Targets Expression Function References
Rhesus monkey and mouse testis
miR449 MECP2, ASB1, BCL2, NOTCH1,




Localized to spermatocytes and
spermatids
Represses the proliferation
of a germ cell line
[129]
miR34b NOTCH1, LGR4, VEZT,
MAN2A2, FOXJ2




miR34a CCND2, BLC2, GMFB, SIRT1 Up-regulation from day 7 to day




miR34c CCND3, CCNG1, CCNB1,
CCNC, CCNE1, CDK4, CDK6,











[130, 131, 134, 135]
miR184 NCOR2 Localized in the germ cell of
mouse testis
Promotes the proliferation
of germ cell line
[136, 137]
miR24 MBD6, H2AX Pachytene spermatocytes Meiosis [136]
miR214 WDTC1, HS proteins Pachytene spermatocytes Meiosis [106, 136]
miR320 Protocadherins All germ cells Cell adhesion [106, 136]





miR18 HSF2 Highly expressed in spermatocytes Male germ cell maturation [108]
miR122a TNP2 In late stage male germ cells Chromatin remodeling [135]
mir355 Rsbn1 Up-regulation in adult testis Transcriptional regulation [130]
miR181b Rsbn1 Up-regulation in adult testis Transcriptional regulation [130]
miR181c Sox5, Sox6, Rsbn1 Up-regulation in adult testis Transcriptional regulation [130]
miR185 RhoA, CDC42 In pachytene spermatocytes Cell cycle regulator [136]
miR191 BNC2 In beta pachytene spermatocytes
Down-regulated in
teratozoospermia
Required for normal sperm
morphology
[136]













[99]. Sertoli cell-specific deletion of Dicer severely impairs
sperm competence and leads to male infertility due to the
absence of mature spermatozoa and testicular degeneration
[97]. Germ cell-specific deletion of Dicer 1 leads to
overexpression of genes for meiotic sex chromosome
inactivation, to increased spermatocyte apoptosis, and to
defects in chromatin organization, the elongation and
nuclear shaping of spermatids [100]. These effects suggest
that Dicers are crucial for the meiotic and haploid phases of
spermatogenesis (Table 3).
MiR-34c expression is up-regulated in spermatocytes
and round spermatids trigger apoptosis [101]. This process
is at least partially mediated by targeting transcription
factor ATF-1 [102]. Thus, miR34c is critical for germ cell
development. MiR-469 has been shown to target transition
protein 2 (TP2) and protamine mRNAs to be repressed in
pachytene spermatocytes and round spermatids [103].
MiR-122a also controls the degradation of TP2 mRNA
cleavage [104], and miR-18 can directly target heat shock
factor 2 mRNA at the spermatogenesis stage [105].
Collectively, miRNAs play essential roles by regulating
each step of male germ cell development, including mito-
sis, meiosis, and spermatogenesis in rodents. Nevertheless,
it remains to be defined which miRNAs are required for the
three major stages of spermatogenesis in humans, including
spermatogonia, pachytene spermatocytes, and round sper-
matids [106]. A better understanding these processes may
provide new targets for the treatment of male infertility.
In vitro gametogenesis from bovine iPSCs
and production of genetically modified (GM) cattle
from transgenic iPSCs
Bovine iPSCs established in our laboratory exhibited
characteristics similar to those of mESCs with regard to
gene expression, transcription factor dependency, and
active signaling molecules [36, 37]. Expression of
pluripotency markers, including OCT4, NANOG, SOX2,
STAT3, c-MYC, KLF4, TERT, and DNMT3A, is main-
tained in bovine iPSCs (Table 3). Mouse ESCs and iPSCs
expressed SSEA-1, but not SSEA-4, whereas human ESCs
and iPSCs expressed SSEA-4, but not SSEA-1 (Table 3).
Morphology and expression of the SSEA antigens in
bovine iPSCs resembled those of mouse ESCs and iPSCs
rather than those of human ESCs and iPSCs. Bovine iPSCs
express both SSEA-1 and SSEA-4. SSEA-1 expression has
been observed in both bovine and equine embryonic stem-
like cells [107–109]. The conditions reported by Hayashi
et al. [19] may be useful for purifying PGC-like cells from
bovine iPSCs (Fig. 1). The availability of functional
in vitro culture system is promising for improving breeding
of farm animals. The selection process for stud sires aiming
to obtaining genetically improved progeny in animal
breeding is very expensive and time-consuming. The use of
fertile sperm cells derived from iPSCs established from the
tissues of neonatal bull calves may be a promising eco-
nomical option. In addition, stem cell therapies may be
useful for restoring fertility in elite bull sires that are
unable to produce semen because of physical damage or
disease of the testicular somatic environment.
Several attempts have been made to establish germ line-
competent bovine ESCs or iPSCs [108–111]; however, so
far teratoma formation with derivatives of the three germ
layers has not been observed, although it has been con-
firmed for goat ESCs [112]. Recently, we demonstrated
that gene expression could be silenced in bovine iPSCs by
using small interfering RNA against p21Cip1, which resul-
ted in the reduced expression of the target genes [36],
suggesting the possibility of gene targeting with bovine
iPSCs.
Spermatozoa may be useful as vectors for producing
GM animals [113–116]. It could be a valuable option in the
cattle industry to use spermatids differentiated from
genetically modified iPSCs to produce transgenic animals
by transplantation into the testes of recipient bull calves or
by injecting them into bovine oocytes. We propose to
produce transgenic animals by using sperm-like cells dif-
ferentiated from transgenic iPSCs via in vitro fertilization
or ICSI. Bovine SSCs could successfully be propagated in
the presence of LIF, epidermal growth factor or fibroblast
growth factor 2; however, no full spermatogenesis was
established from SSCs transplanted into recipient mouse
testis [117]. Complete spermatogenesis has been obtained
from autologous transfer of bovine SSCs [47, 48, 118].
Thus, the methodologies described above need significant
improvements, and cell-based approaches in livestock
reproduction are a challenging task. The derivation of PSCs
in livestock is promising for the development of novel
disease-resistance strategy, cell or organ therapies, drug
screening, and human disease models. It is also important
for increasing the efficiency of the livestock industry. For
example, dairy manufacturers could derive protein-rich
milk from GM cows and thereby reduce the cost of cheese
production.
The rapidly emerging DNA nucleases such as ZFNs,
TALEN, and CRISPR/Cas may provide additional new
options for producing livestock species with targeted
genetic modifications with novel traits useful for applica-
tion in agriculture and biomedicine [119]. There is no
doubt that the application of genetic modifications and PSC
techniques will improve our understanding of the dynamics
of gametogenesis and reproductive biology in general, and
will play an important role in the development of novel
therapeutic treatments in humans and other mammalian
species.













Over the past decade, revolutionary progress has been
made in the derivation and characterization of germ cells
from various types of stem cells. SSC transplantation in
non-human primates is now compatible with functional
spermatogenesis in infertile testes after chemotherapy,
clearly showing the possibility of using human SSCs from
tissue biopsies of adolescent male patients to obtain func-
tional germ cells prior to treatment with high-dose
chemotherapy. However, transplantation of human ESC-
derived gametes may be associated with incompatibilities
of the immune systems, although the testicles constitute an
immune-privileged site. Therefore, iPSCs may be a suit-
able option for supplying sufficient numbers of autologous
cells. Differentiated spermatid-like cells from human
iPSCs have been unable to fertilize human oocytes until
now. More feasible and safer systems must be established
in animal models, including large domestic livestock spe-
cies, to improve the low efficiency of current
differentiation protocols and cell viability. From both the
academic and therapeutic point of view, in vitro differen-
tiation models using PSCs are highly promising areas. The
self-renewal capacity and the pluripotency of stem cells
may be valuable in preserving individual genomes and
modifying germ lines.
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